Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,242 | 327 | 98.2% |
| Education | $97.00 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $699.34 | 31 | $0 (2024) |
| Novo Nordisk Inc | $670.51 | 50 | $0 (2024) |
| PFIZER INC. | $456.53 | 35 | $0 (2024) |
| Lilly USA, LLC | $431.38 | 24 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $395.43 | 20 | $0 (2024) |
| ABBVIE INC. | $374.24 | 28 | $0 (2024) |
| Abbott Laboratories | $212.15 | 29 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $202.76 | 12 | $0 (2024) |
| Exact Sciences Corporation | $194.63 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $192.80 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,166 | 135 | AstraZeneca Pharmaceuticals LP ($354.69) |
| 2023 | $2,558 | 156 | Novo Nordisk Inc ($354.37) |
| 2022 | $615.19 | 37 | Novo Nordisk Inc ($97.92) |
All Payment Transactions
328 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.11 | General |
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Central Nervous System | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: DIABETES | ||||||
| 10/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.80 | General |
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 582 | 1,307 | $183,255 | $52,969 |
| 2022 | 7 | 191 | 211 | $39,683 | $14,478 |
| 2021 | 4 | 66 | 89 | $5,432 | $1,735 |
| 2020 | 3 | 51 | 65 | $5,793 | $826.69 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 403 | $96,720 | $25,391 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 296 | $50,320 | $14,324 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $17,812 | $7,833 | 44.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $5,264 | $2,194 | 41.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 89 | 89 | $3,115 | $1,369 | 43.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 71 | $3,266 | $621.33 | 19.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 14 | $2,380 | $577.76 | 24.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 24 | $720.00 | $389.28 | 54.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 32 | $192.00 | $109.12 | 56.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 124 | $496.00 | $99.33 | 20.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 29 | 165 | $2,970 | $62.01 | 2.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 78 | $18,720 | $6,369 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 54 | $9,180 | $3,292 | 35.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 15 | 15 | $4,935 | $2,107 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $3,904 | $1,757 | 45.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 15 | 16 | $1,184 | $563.88 | 47.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 15 | 15 | $525.00 | $232.20 | 44.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 17 | $1,235 | $156.68 | 12.7% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 30 | 35 | $2,590 | $1,237 | 47.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 14 | 25 | $1,817 | $234.98 | 12.9% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 11 | 14 | $725.06 | $231.42 | 31.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 11 | 15 | $300.15 | $32.06 | 10.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 22 | 35 | $2,543 | $332.47 | 13.1% |
| 87804 | Detection test for influenza virus | Office | 2020 | 14 | 15 | $2,473 | $247.26 | 10.0% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 15 | 15 | $776.85 | $246.96 | 31.8% |
About Jessica Marcus
Jessica Marcus is a Family healthcare provider based in Princeton, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2019. The National Provider Identifier (NPI) number assigned to this provider is 1609427350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Marcus has received a total of $5,339 in payments from pharmaceutical and medical device companies, with $2,166 received in 2024. These payments were reported across 328 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,242).
As a Medicare-enrolled provider, Marcus has provided services to 890 Medicare beneficiaries, totaling 1,672 services with total Medicare billing of $70,009. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Princeton, WV
- Active Since 09/24/2019
- Last Updated 09/10/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1609427350
Products in Payments
- REXULTI (Drug) $382.80
- MOUNJARO (Drug) $346.97
- BREZTRI (Drug) $313.68
- FARXIGA (Drug) $307.70
- Ozempic (Drug) $227.35
- FREESTYLE LIBRE 3 (Device) $212.15
- VRAYLAR (Drug) $209.33
- XIFAXAN (Drug) $202.76
- Cologuard Collection Kit (Device) $194.63
- Rybelsus (Drug) $178.80
- PREVNAR 20 (Biological) $177.44
- Wegovy (Drug) $165.02
- Dexcom G6 Transmitter (Medical Supply) $157.64
- CERVIDIL (Drug) $157.00
- TRINTELLIX (Drug) $147.79
- TRELEGY ELLIPTA (Drug) $145.10
- NURTEC ODT (Drug) $134.79
- JARDIANCE (Drug) $134.25
- Veozah (Drug) $102.47
- Kerendia (Drug) $94.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Princeton
Leigh Brooks, Aprn Fnp-C, APRN FNP-C
Family — Payments: $57,120
Mrs. Angela Akers, Np, NP
Family — Payments: $15,575
Rhonda Ray, Crnp, CRNP
Family — Payments: $7,825
Sabrina Huffman, Msn, Fnp, MSN, FNP
Family — Payments: $5,962
Jessica Deel, Np-C, NP-C
Family — Payments: $5,473
Mrs. Brooke Kirk, Fnp-Bc, FNP-BC
Family — Payments: $4,475